119-HR9661FEDERALIn Committee
Expedited Access to Biosimilars Act
Latest action: Referred to the House Committee on Energy and Commerce.
Voted: 7/14/2026Source
How representatives voted
0 yea·0 nay
No roll-call votes recorded for this bill yet.
Latest action: Referred to the House Committee on Energy and Commerce.
0 yea·0 nay
No roll-call votes recorded for this bill yet.